 | |
| Company type | Public company |
|---|---|
| NYSE: DNA (Class A) | |
| Industry | Biotechnology |
| Founded | 2008 in Boston, Massachusetts, U.S. |
| Founders | Tom Knight, Jason Kelly, Reshma Shetty, Barry Canton, Austin Che[1] |
| Headquarters | , U.S. |
Key people | Shyam Sankar (Chair Board of Directors), Jason Kelly (CEO) |
| Revenue |  US$478 million (2022) |
 US$−2.2 billion (2022) | |
| US$−2.1 billion (2022) | |
| Total assets | US$2.54 billion (2022) |
| Total equity | US$1.74 billion (2022) |
Number of employees | 1,218 (December 31, 2023) |
| Website | ginkgobioworks |
| Footnotes / references [2] | |
Ginkgo Bioworks is an American biotech company founded in 2008 by five scientists from MIT,[3] headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology.[4][5][6][7] The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies,[8] valued at $4.2 billion in 2019.[9] It raised $290 million in September and $350 million in October of that year.[8] Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.[10]
- ^ Cite error: The named reference
:2was invoked but never defined (see the help page). - ^ Ginkgo Bioworks Holdings, Inc. 2022 Annual Report (Form 10-K). U.S. Securities and Exchange Commission. 13 March 2023. pp. 31, F-4, F-5.
- ^ Logan, Tim (3 April 2021). "Ginkgo Bioworks aims to keep growing with new building in Seaport". Boston Globe. p. D1. Retrieved 23 December 2022 – via Newspapers.com.
- ^ Molteni, Megan (14 September 2017). "With Designer Bacteria, Crops One Day Could Fertilize Themselves". Wired. Archived from the original on 5 December 2017. Retrieved 4 December 2017.
- ^ Herper, Mathew (8 June 2016). "Boston Startup Raises $100 Million To Use Synthetic Biology To Design Microbes For Industry". Forbes. Archived from the original on 9 Jun 2016. Retrieved 4 December 2017.
- ^ Adams, Susan (14 September 2017). "Bayer And Ginkgo Bioworks, A Startup, Aim To Make Crops Produce Their Own Nitrogen Fertilizer". Forbes. Archived from the original on 5 December 2017. Retrieved 4 December 2017.
- ^ Weisman, Robert (29 September 2016). "Ginkgo Bioworks opens production site for custom cells". Boston Globe. Retrieved 4 December 2017.
- ^ a b Spalding, Rebecca (9 October 2019). "Ginkgo Bioworks raises $350 million fund for biotech spinouts". Reuters. Archived from the original on 7 November 2019. Retrieved 7 November 2019.
- ^ Weber, Joel (6 November 2019). "Ginkgo Bioworks CEO Wants Biology to Manufacture Physical Goods". Bloomberg News. Archived from the original on 9 November 2019. Retrieved 7 November 2019.
{{cite news}}: CS1 maint: bot: original URL status unknown (link) - ^ Cite error: The named reference
goespublicwas invoked but never defined (see the help page).
© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search